¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Alpha heavy chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Fordyce¡¯s disease
    Æ÷´ÙÀ̽ºº´
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • fungal disease
    Áø±ÕÁúȯ, °õÆÎÀ̺´
  • fusospirochetal disease
    ¹æÃß±Õ½ºÇÇ·ÎÇ쟺´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸·º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • Greenfield¡¯s disease
    ±×¸°Çʵ庴
  • Hartnup¡¯s disease
    ÇÏÆ®³Òº´
  • Hashimoto¡¯s disease
    ÇϽøðÅ亴
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴, °ú´ÙÁö¹æÀ¯Çິ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • glucose storage disease
    ´çÃàÀûº´
  • glycogen storage disease
    ´ç¿øÃàÀûº´
  • graft-versus-host disease
    À̽Ĵë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hansen¡¯s disease
    (¢¡leprosy) ³ªº´
  • hard pad disease
    °æÃ´Áõ
  • heart disease
    ½ÉÀ庴
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´
  • helminthic disease
    ¿¬Ã溴
  • hemisoimmune disease
    ÀûÇ÷±¸µ¿Á¾¸é¿ªº´
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemolytic disease
    ¿ëÇ÷º´, ¿ëÇ÷Áúȯ
  • hemorrhagic disease
    ÃâÇ÷º´
  • hemp disease
    ¸¶¼¶À¯º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Di Guglielmos disease
    µð±¸±Û¸®¿¤¸ðº´, ÀûÇ÷º´¼º °ñ¼öÁõ.
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Dowling-Degos disease = reticular pigmented anomaly of the flexures
    ±¼ÃøºÎ ¸Á»ó»ö¼ÒÀÌ»ó(Áõ)
  • Duhrings disease => dermatitis herpetiformis
    Æ÷Áø»ó ÇǺο°
  • Duncans disease .
    ´øÄ­¾¾º´
  • Eagles disease
    À̱۽ºº´
  • Eales disease
    ÀϽºº´
  • Ebola disease
    ¿¡º¼¶óº´
  • Ebola disease
    ¿¡º¼¶ó º´
  • Fabrys disease
    ÆÄºê¸®º´
  • Fabrys disease
    ÆÄºê¸®º´.
  • Fabrys disease
    ÆÄºê¸®º´
  • Farber s disease
    ÆÄ¾Æ¹öº´.
  • Fordyce s disease
    Æ÷¿À´ÙÀ̽ºº´.
  • Fordyces disease
    Æ÷´ÙÀ̽ºº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • side chain isomerism
    Ãø¼âÀ̼º(ö°áðì¶àõ).
  • side chain theory
    Ç×ü»ý»êÃø¼â¼³
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ.
  • sympathetic chain
    ±³°¨½Å°æ»ç½½
  • sympathetic ganglion chain
    ±³°¨½Å°æÀý¿¬¼â(¡­ææáð).
  • blood disease =hemic disease
    Ç÷¾×Áúȯ(Ì´Ëâ̷̤).
  • blood disease =hemic disease
    Ç÷¾×Áúȯ(úìäûòðü´).
  • accumulation disease
    ÃàÀûº´(õëîÝÜ»).
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired disease
    ÈÄõ¼º Áúº´(¡­òðÜ»).
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
CAD cadaver, cadaveric; cold agglutinin disease; compressed air disease; computer-assisted design; compu...
CSD carotid sinus denervation; cat scratch disease; combined system disease; conditionally streptomycin ...
CVD cardiovascular disease; cerebrovascular disease; collagen vascular disease; color-vision-deviant
GBD gallbladder disease; gender behavior disorder; glass blower's disease; granulomatous bowel disease
GD gastroduodenal; Gaucher disease; general diagnostics; general dispensary; gestational day; Gianotti ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
8-epi-PGF2 alpha 8-Epi-prostaglandin F2 alpha
8-iso-PGF(2 alpha) 8-Iso-prostaglandin F(2 alpha
alpha-FP ALPHA-Fetoprotein
alpha 1-AT Alpha 1 antitrypsin
alpha 1-m Alpha 1-Microglobulin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ
  • hepatocerebral disease
    °£ ³ú ÁõÈıº
    Àª½¼ º´°ú À̳뼼ÇüÀ¸·Î Å©°Ô ³ª´­ ¼ö ÀÖ´Ù. Àª½¼ º´Àº ¼±Ãµ¼ºÀÎ °áÇÔÀ¸·Î ÀÎÇÑ ±¸¸® ´ë»ç ÀÌ»óÀ¸·Î¼­, °£ ¹× ³ú¿¡ ´Ù·®ÀÇ ±¸¸®°¡ Ä§ÂøÇÑ´Ù. °£Àº ÇöÀúÇÑ °æº¯ÁõÀ» ³ªÅ¸³»°í, °£ ±â°£ºÎÀÇ ·»Áî ÇÙÀ̳ª Çǰ¢ µî¿¡ º¯¼ºÀÌ »ý±ä´Ù. ÇÇ, ¿ÀÁÜ ¼ÓÀÇ ±¸¸®´Â ºÒ¾î³ª³ª, Ç÷¾× ¼ÓÀÇ ±¸¸® °áÇÕ ´Ü¹éÁúÀÎ ¼¿·ê·Î Çö󽺹ÎÀº °¨¼ÒÇÏ°í °¢¸·¿¡ Ä«ÀÌÀú ÇöóÀ̼ŠȯÀÌ »ý±ä´Ù. À̳뼼Çü Áß °£ ¿ÜÇüÀº °£ Áúȯ ½Ã¿¡ °£ ³» Ç÷·ù°¡ °ï¶õÇÏ°Ô µÈ °á°ú, °£ ¿ÜÀÇ ´Ü¶ôÀ» ÅëÇÏ¿© ³»¸ÆÇ÷ÀÌ ±×´ë·Î ½ºÃÄ Áö³ª°¡±â ¶§¹®¿¡ Ç÷¾× ¼ÓÀÇ ¾Ï¸ð´Ï¾Æ °ªÀÌ »ó½ÂÇÏ¿© ³ú Áõ»óÀ» ÀÏÀ¸Å²´Ù. °£³»ÇüÀº ÁÖ·Î Áö¹æ¼º °£ °æº¯Áõ µî¿¡¼­ °£ ³»ÀÇ ´Ü¶ôÀ» ±×´ë·Î ºüÁ®³ª°¡±â ¶§¹®¿¡ À§¿Í °°Àº °á°ú¸¦ °¡Á®¿À´Â °ÍÀ» ¸»ÇÑ´Ù.
  • hereditary disease
    À¯Àüº´
    À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ½ÅüÀû, Á¤½ÅÀûÀÎ ÀÌ»óÀÇ ÃÑĪ. À¯Àü¼º ÁúȯÀ̶ó°íµµ ÇÑ´Ù. º´, ÀÌ»ó ÇüÁúÀÌ À¯ÀüÀû ¿äÀΰú °ü·ÃÀÌ ÀÖÀ½¿¡ µû¶ó¼­ ¹Ýµå½Ã À¯ÀüÀÚ¿¡ ÀÇÇÏÁö ¾Ê´Â À¯ÀüÀûÀÎ º´µµ À¯Àüº´À̶ó°í ÇÏ°Ô µÇ¾ú´Ù. 1°³ÀÇ ¿ì¼º À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÇåÆÃÅÏ ¹«µµº´, ¹ß·»ºÎ¸£Å© ÁõÈıº, ¿­¼º À¯ÀüÀÚÀÇ µ¿Çü Á¢ÇÕ¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª´Â ¹éÀÚ, Æä´ÒÄÉÅæ´¢Áõ, X ¿°»öü À§ÀÇ ¹Ý¼º À¯ÀüÀÚ¿¡ ÀÇÇÑ Àû·Ï »ö¸Í, Ç÷¿ìº´, ÁøÇ༺ ±Ù µð½ºÆ®·ÎÇÇÁõ µîÀº ¸í¹éÈ÷ ÀÌÀ¯ ÀüÀÚ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, À¯Àüº´ÀÇ ´ëÇ¥ÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ¹Ý¼º À¯ÀüÀÚ´Â X ¿°»öü À§¿¡ À§Ä¡ÇÏ´Â °Í¸¸ ¾Ë·ÁÁ® ÀÖ°í, ³²¼ºÀ» °áÁ¤ÇÏ´Â Y ¿°»öü À§¿¡´Â ÇöÀç±îÁö ƯÈ÷ È®½ÇÇÑ ÇüÁúÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù°í º¸°í ÀÖ´Ù. À¯ÀüÀÚ¿¡ ÀÇÇÑ ÀÌ»óÀ̳ª º´Àº Ãâ»ýÇÏ´Â ¾Æ±âÀÇ 1 %°¡ ÀÌ¹Ì °¡Áö°í Àְųª ¹ßº´ÇÒ °¡´É¼ºÀ» Áö´Ï°í ÀÖ´Ù. ¿°»öüÀÇ ±¸Á¶ ¶Ç´Â ±¸¼ºÀÇ ÀÌ»ó¿¡ ÀÇÇÏ¿© ÀϾ´Â ¿©·¯ °¡Áö ÀÌ»ó ´Ù¿î ÁõÈıº, ÅÍ³Ê ÁõÈıº, Ŭ¶óÀÎÆçÅÍ ÁõÈıº µîµµ ¿°»öü À§¿¡ À¯ÀüÀÚ°¡ ÀÖ´Ù°í ÇÏ´Â Àǹ̿¡¼­´Â À¯ÀüÇÐÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ±×·¯³ª ´ë°³´Â ÀÌ»ó °³Ã¼¸¦ ¸¸µç ¹è¿ìÀÚ
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
  • HIV disease
    ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ
  • Hodgkin's disease
    È£ÁîŲ º´, È£ÁöŲ º´, Hodgkin º´
    µ¿ÀǾî=malignant lym
  • hunger disease
    ±â¾Æ º´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
    ¹Ì¼÷¾Æ¿¡¼­ Ãâ»ý Á÷ÈÄ ¹ß»ýÇÏ´Â °¡Àå ÈçÇÑ Áúº´ Áß Çϳª·Î¼­ ½Å»ý¾Æ »ç¸ÁÀÇ Áß¿ä ¿øÀÎÁß ÇϳªÀÌ´Ù.
  • hydatid disease
    Æ÷ÃæÁõ, Æ÷Ãæº´
  • hypokinetic disease
    µµÈ¸º´, ¿îµ¿ ºÎÁ· º´
  • idiopathic disease
    Ư¹ßº´
    ´Ù¸¥ ÁúȯÀÇ °á°ú·Î ¹ß»ýÇÏÁö ¾Ê´Â Áúº´À¸·Î¼­, ¿øÀÎÀº ºÒ¸íÀÌ´Ù.
  • immune deficiency disease
    ¸é¿ª °áÇÌ Áúȯ, ¸é¿ª °áÇ̺´
    ¸é¿ª °èÅëÀ» ±¸¼ºÇÏ´Â ¿ä¼ÒÀÇ ±â´É Àå¾Ö¿¡ ÀÇÇÏ¿© ÃÊ·¡µÇ´Â Áúȯ ±º.
  • immunologic disease
    ¸é¿ª Áúȯ, ¸é¿ªÇÐÀû Áúȯ
  • inclusion body disease
    ºÀÀÔü º´
    ¼¼Æ÷ ºÀÀÔü°¡ ³ªÅ¸³ª´Â Áúȯ. ƯÈ÷ ¹ÙÀÌ·¯½º º´¿¡¼­ ÈçÇÏ´Ù.
  • infectious disease
    °¨¿° Áúȯ, °¨¿°¼º Áúȯ, °¨¿°º´, Àü¿°º´
    °¨¿°À» ÀÏÀ¸Å°´Â ¼÷ÁÖ´Â Á¦°¢±â º´¿øÃ¼¿¡ ´ëÇØ¼­ ƯÀ¯ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»°í ¹ÝÀÀÀÇ º´ÀûÀÎ Á¤µµ¿¡ ´ÞÇØ ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³­ ÁúȯÀ» ¸»ÇÑ´Ù. °¨¿°À» ÀÏÀ¸Äѵµ ¹Ýµå½Ã ¹ßº´ÇÑ´Ù°í´Â ÇÒ ¼ö ¾ø°í ±× º´¿øÃ¼ÀÇ Á¾·ù, º´¿øÃ¼ÀÇ °¨¿°·Â¿¡ °üÇÑ ÀÎÀÚ¿Í °¨¿°ÇÑ »ýüÀÇ °¨¼ö¼º, ¸é¿ª, ±× ¹ÛÀÇ ÀúÇ׷¿¡ °üÇÑ ÀÎÀÚ¿ÍÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ °áÁ¤µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
alpha-d-glucosidase A glucohydrolase removing terminal nonreducing 1,4-linked alpha-glucose residues by hydrolysis, yielding alpha-glucose; a deficiency of the lysosomal enzyme is associated with glycogen storage disease type II. There are at least five isozymes of maltase.
Synonym: glucoinvertase.
(05 Mar 2000)
alpha-D-mannose-beta-1,2-N-acetylglucosaminyltransferase <enzyme> Absolute specificity for terminal branched mannosyl residues of glycolipids
Registry number: EC 2.4.1.-
Synonym: udpgnac-1,2-magtransferase
(26 Jun 1999)
alpha-D-xylosidase <enzyme> Highly specific for 4-nitrophenyl alpha-d-xylopyranoside and isoprimeverose; can also split off the alpha-d-xylopyranosyl residue on the non-reducing terminal of the backbone of certain oligoxyloglucans
Registry number: EC 3.2.1.-
Synonym: alpha-d-xylosidase I, alpha-d-xylosidase II
(26 Jun 1999)
alpha emission <physics> Form of nuclear decay where the nucleus emits an alpha particle (see entry below).
(09 Oct 1997)
alpha-endorphin <chemical> An endogenous opioid peptide derived from the pro-opiomelanocortin precursor. It differs from gamma-endorphin by one amino acid.
Chemical name: alpha-Endorphin
(12 Dec 1998)
alpha error The statistical error (said to be of the first kind or type I) made in testing an hypothesis when it is concluded that a result is positive when it really is not. Alpha error is often referred to as a false positive.
(12 Dec 1998)
alpha-farnesene 3,7,11-Trimethyl-1,3,6,10-dodecatetraene;a straight open-chain hydrocarbon built up of three isoprene units; one of the four isomeric forms occurs in the natural coating of apples.
(05 Mar 2000)
alpha-fetoprotein <protein, tumour marker> A protein substance that is normally produced by the liver cells.
It is one of the first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states.
Measurement of the alpha-fetoprotein level in the bloodstream has been used as a early detection test for some forms of cancer (hepatocellular carcinoma). Alpha-fetoprotein can also be an important marker in the fluid obtained by amniocentesis for the prenatal diagnosis of anencephaly and other open neural tube defects such as spina bifida.
Elevated in: wrong dates for a pregnancy, multiple gestation, midline closure (neural-tube) defects, encephalocele, anencephaly, liver tumours, hepatoblastoma, haemangioendothelioma (occasionally, mild), hepatocellular carcinoma (HCC, hepatoma). The level produced by liver tumours (hepatomas), germ cell tumours (teratocarcinoma and embryonal cell carcinomas) permits the monitoring of response to treatment of these tumours.
Decreased in: wrong dates for a pregnancy, chromosome abnormality (including Down syndrome)
Acronym: AFP
(27 Jun 1999)
alpha-fetoproteins Increases in maternal blood during pregnancy and, when detected by amniocentesis, is an important indicator of open neural tube defects and is also used as a tumour marker in adults with hepatocellular carcinoma, beta-fetoproteins, although a foetal liver protein, has been detected in adult patients with liver disease, gamma-fetoproteins occurs in various neoplasms.
See: fetoglobulins.
(05 Mar 2000)
alpha fibres Large somatic motor or proprioceptive nerve fibre's conducting impulses at rates near 100 m/sec.
(05 Mar 2000)
alpha-fucosidase <enzyme> An enzyme that catalyses the hydrolysis of an an alpha-l-fucoside, producing an alcohol and l-fucose; a deficiency of the lysosomal enzyme will result in fucosidosis.
(05 Mar 2000)
alpha-galactosidase <enzyme> An enzyme that catalyses the hydrolysis of terminal, non-reducing alpha-d-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids.
Chemical name: alpha-D-Galactoside galactohydrolase
Registry number: EC 3.2.1.22
(12 Dec 1998)
alpha-globulin <protein> The serum globulins with the most rapid electrophoretic migration, further subdivided into faster alpha(1)- and slower alpha(2)-globulins.
(12 Dec 1998)
alpha-glucan branching glycosyltransferase 1,4-alpha-d-glucan branching enzyme
alpha-glucan phosphorylase <enzyme> Enzyme that catalyses the sequential removal of glycosyl residues from glycogen to yield one glucose-1-phosphate per reaction. Its activity is controlled by phosphorylation (by phosphorylase kinase).
(21 Jun 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á